山东药玻
(600529)
| 流通市值：120.58亿 | | | 总市值：120.58亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,280,395,300.46 | 1,219,063,985.04 | 4,474,018,978.75 | 3,352,070,071.23 |
| 营业总成本 | 1,815,722,108.72 | 960,424,944.76 | 3,533,710,798.9 | 2,658,703,139.69 |
| 其他经营收益 | | | | |
| 营业利润 | 455,984,384.37 | 241,794,104.58 | 837,960,826.94 | 651,866,577.9 |
| 利润总额 | 452,355,188.08 | 239,229,487.78 | 830,828,068.79 | 648,391,295.8 |
| 净利润 | 370,867,951.66 | 201,206,020.13 | 689,626,040.66 | 542,453,658.37 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 370,867,951.66 | 201,206,020.13 | 689,626,040.66 | 542,453,658.37 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 6,125,630,212.14 | 6,106,789,974.14 | 6,012,161,093.16 | 5,796,596,188.31 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,002,795,301.62 | 4,029,838,028.8 | 4,031,608,632.22 | 4,085,758,516.84 |
| 资产总计 | 10,128,425,513.76 | 10,136,628,002.94 | 10,043,769,725.38 | 9,882,354,705.15 |
| 流动负债: | | | | |
| 流动负债合计 | 1,440,133,220.24 | 1,611,972,910.4 | 1,601,199,646.03 | 1,605,866,076.13 |
| 非流动负债: | | | | |
| 非流动负债合计 | 142,674,647.86 | 148,311,102.72 | 147,927,922.87 | 127,414,007.84 |
| 负债合计 | 1,582,807,868.1 | 1,760,284,013.12 | 1,749,127,568.9 | 1,733,280,083.97 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,545,617,645.66 | 8,376,343,989.82 | 8,294,642,156.48 | 8,149,074,621.18 |
| 股东权益合计 | 8,545,617,645.66 | 8,376,343,989.82 | 8,294,642,156.48 | 8,149,074,621.18 |
| 负债和股东权益合计 | 10,128,425,513.76 | 10,136,628,002.94 | 10,043,769,725.38 | 9,882,354,705.15 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,418,614,396.11 | 1,144,890,161.95 | 4,555,263,360.65 | 4,029,175,063.03 |
| 经营活动现金流出小计 | 2,017,762,325.95 | 931,900,710.73 | 3,978,338,397.29 | 3,518,218,534.81 |
| 经营活动产生的现金流量净额 | 400,852,070.16 | 212,989,451.22 | 576,924,963.36 | 510,956,528.22 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 3,508,264,602.65 | 2,295,990,305.84 | 8,023,272,106.76 | 6,156,698,640.54 |
| 投资活动现金流出小计 | 2,577,408,071.62 | 1,031,041,960.34 | 8,171,864,537.19 | 6,515,042,423.88 |
| 投资活动产生的现金流量净额 | 930,856,531.03 | 1,264,948,345.5 | -148,592,430.43 | -358,343,783.34 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 104,343,305.53 | 2,079,383.31 | 376,750,003.57 | 370,341,793.4 |
| 筹资活动产生的现金流量净额 | -104,343,305.53 | -2,079,383.31 | -376,750,003.57 | -370,341,793.4 |
| 汇率变动对现金及现金等价物的影响 | -11,298,295.81 | -5,991,709.37 | 5,793,613.61 | 7,322,055.64 |
| 现金及现金等价物净增加额 | 1,216,066,999.85 | 1,469,866,704.04 | 57,376,142.97 | -210,406,992.88 |
| 期末现金及现金等价物余额 | 2,158,624,504.53 | 2,412,424,208.72 | 942,557,504.68 | 674,774,368.83 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 1,216,066,999.85 | - | 57,376,142.97 | - |
最新报告期：2026-09-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 长江证券 | 李浩,范超 | 1.22 | 1.36 | 1.50 | 2026-09-08 |
| 光大证券 | 鲁俊,孙伟风 | 1.15 | 1.37 | 1.45 | 2026-08-31 |
| 国联民生 | 武慧东 | 1.20 | 1.37 | 1.53 | 2026-08-27 |